Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. by Plummer, E, Middleton, M, Jones, C, Olsen, A, Hickson, I, McHugh, P, Margison, G, McGown, G, Thorncroft, M, Watson, A, Boddy, A, Calvert, A, Harris, A, Newell, DR, Curtin, N

Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. by Arris, C, Boyle, F, Calvert, A, Curtin, N, Endicott, J, Garman, E, Gibson, A, Golding, B, Grant, S, Griffin, R, Jewsbury, P, Johnson, L, Lawrie, A, Newell, DR, Noble, M, Sausville, E, Schultz, R, Yu, W

Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy by Willoughby, CE, Jiang, Y, Thomas, HD, Willmore, E, Kyle, S, Wittner, A, Phillips, N, Zhao, Y, Tudhope, SJ, Prendergast, L, Junge, G, Lourenco, LM, Finlay, MRV, Turner, P, Munck, JM, Griffin, RJ, Rennison, T, Pickles, J, Cano, C, Newell, DR, Reeves, HL, Ryan, AJ, Wedge, SR